HIV drug resistance testing

HIV drug resistance testing

Phenotype testing AIDS The testing of various agents–eg, reverse transcriptase inhibitors, for efficacy against a particular strain of HIV Types Genotypic tests1, phenotypic test. Cf Genotype testing.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Receipt and timing of HIV drug resistance testing in six U.S.
"Now we have the opportunity to do HIV drug resistance testing much faster, at a lower cost and also to test for mutations that are not visible with Sanger sequencing.
Patients who did not achieve virological suppression were retained in the intervention and assessed for HIV drug resistance testing.
The two fundamental approaches to HIV drug resistance testing are:
available data support a role for HIV drug resistance testing in selecting drugs in many clinical situations."[1] These situations include, according to the panel, the use of resistance assays in treatment naive patients with chronic infection, even as the panel concedes that the absence of selective drug pressure in this population means that drug-resistant mutants "...
Two new prospective trials examining the utility of HIV drug resistance testing in clinical management were presented in their entirety for the first time, and both of these new studies employed phenotypic resistance testing (PRT).